Clinical Trials Directory

Trials / Completed

CompletedNCT02735122

Study of Acetaminophen (ACM) in Post-operative Dental Pain

A Randomized, Double-Blind, Placebo- and Active- Controlled, Single-Dose, Efficacy, Safety, and Pharmacokinetics Study of a Test Acetaminophen 500 mg Tablet in Postoperative Dental Pain

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
420 (actual)
Sponsor
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · Industry
Sex
All
Age
17 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This is a Dental Pain Study which will evaluate the analgesic onset, efficacy and safety of 1000 mg acetaminophen as two Test acetaminophen 500 mg tablets, compared with commercial products of acetaminophen 1000 mg administered as two 500 mg caplets, and ibuprofen (IBU) 400 mg following third molar (wisdom tooth) extraction.

Detailed description

This is a single-dose, randomized, double-blind, triple-dummy, placebo- and active controlled, parallel-group study to evaluate the analgesic onset, efficacy, and safety profile of Test acetaminophen 1000 mg compared with two commercial products over a six-hour period after third-molar extractions. Subjects will undergo dental extraction of three or four third molars.

Conditions

Interventions

TypeNameDescription
DRUGacetaminophen Tablet2 test acetaminophen 500 mg tablets
DRUGacetaminophen Caplet2 commercial acetaminophen 500 mg caplets
DRUGibuprofen Liquid-filled capsule2 commercial ibuprofen 200 mg Liquid-filled capsules
DRUGPlacebo Tablet2 placebo tablets
DRUGPlacebo Caplet2 placebo caplets
DRUGPlacebo Liquid-filled capsule2 placebo Liquid-filled capsules

Timeline

Start date
2016-04-30
Primary completion
2016-10-05
Completion
2016-10-05
First posted
2016-04-12
Last updated
2022-09-28

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02735122. Inclusion in this directory is not an endorsement.